Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide is an investigational peptide compound that simultaneously activates three key hormone receptors: glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1). This unique triple agonist mechanism makes it a promising candidate for obesity and metabolic disorder research.
The white powder formulation of Retatrutide maintains excellent stability with a shelf life of 2 years when stored properly. Clinical studies have demonstrated its potential to significantly improve glycemic control and lipid metabolism in research models, while also exhibiting notable weight loss effects.
As a research chemical, this high purity (≥99%) Retatrutide peptide powder is strictly for laboratory use only. Researchers should handle it with appropriate precautions and follow all applicable regulations for peptide compounds.
The compound's multi-receptor activation profile suggests potential applications in studying metabolic pathways, weight regulation mechanisms, and glucose homeostasis. Early research indicates weekly administration may produce significant metabolic effects, making it particularly interesting for chronic condition research models.